for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Ipsen Obtains FDA's Fast Track designation For ONIVYDE

June 17 (Reuters) - Ipsen SA:

* OBTAINS FAST TRACK DESIGNATION FROM FDA FOR LIPOSOMAL IRINOTECAN (ONIVYDE®) AS COMBINATION TREATMENT FOR METASTATIC PANCREATIC CANCER Source text for Eikon: Further company coverage: (Gdansk Newsroom)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up